Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis

被引:25
|
作者
Nakanishi, Yutaka [1 ]
Shiraha, Hidenori [1 ]
Nishina, Shin-ichi [1 ]
Tanaka, Shigetomi [1 ]
Matsubara, Minoru [1 ]
Horiguchi, Shigeru [1 ]
Iwamuro, Masaya [1 ]
Takaoka, Nobuyuki [1 ]
Uemura, Masayuki [1 ]
Kuwaki, Kenji
Hagihara, Hiroaki
Toshimori, Junichi
Ohnishi, Hideki [1 ]
Takaki, Akinobu [1 ]
Nakamura, Shinichiro [1 ]
Kobayashi, Yoshiyuki [1 ]
Nouso, Kazuhiro [1 ,2 ]
Yagi, Takahito [3 ]
Yamamoto, Kazuhide [1 ]
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med & Dent, Dept Mol Hepatol, Okayama 7008558, Japan
[3] Okayama Univ, Grad Sch Med & Dent, Dept Gastroenterol Surg Transplant & Surg Oncol, Okayama 7008558, Japan
来源
BMC CANCER | 2011年 / 11卷
关键词
TUMOR-SUPPRESSOR GENES; GASTRIC-CANCER; PANCREATIC-CANCER; BCL-2; FAMILY; P53; GENE; PROTEIN; CARCINOGENESIS; INACTIVATION; PROMOTER; LINES;
D O I
10.1186/1471-2407-11-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Runt-related transcription factor 3 (RUNX3) is known as a tumor suppressor gene for gastric cancer and other cancers, this gene may be involved in the development of hepatocellular carcinoma (HCC). Methods: RUNX3 expression was analyzed by immunoblot and immunohistochemistry in HCC cells and tissues, respectively. Hep3B cells, lacking endogenous RUNX3, were introduced with RUNX3 constructs. Cell proliferation was measured using the MTT assay and apoptosis was evaluated using DAPI staining. Apoptosis signaling was assessed by immunoblot analysis. Results: RUNX3 protein expression was frequently inactivated in the HCC cell lines (91%) and tissues (90%). RUNX3 expression inhibited 90 +/- 8% of cell growth at 72 h in serum starved Hep3B cells. Forty-eight hour serum starvation-induced apoptosis and the percentage of apoptotic cells reached 31 +/- 4% and 4 +/- 1% in RUNX3-expressing Hep3B and control cells, respectively. Apoptotic activity was increased by Bim expression and caspase-3 and caspase-9 activation. Conclusion: RUNX3 expression enhanced serum starvation-induced apoptosis in HCC cell lines. RUNX3 is deleted or weakly expressed in HCC, which leads to tumorigenesis by escaping apoptosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis
    Yutaka Nakanishi
    Hidenori Shiraha
    Shin-ichi Nishina
    Shigetomi Tanaka
    Minoru Matsubara
    Shigeru Horiguchi
    Masaya Iwamuro
    Nobuyuki Takaoka
    Masayuki Uemura
    Kenji Kuwaki
    Hiroaki Hagihara
    Junichi Toshimori
    Hideki Ohnishi
    Akinobu Takaki
    Shinichiro Nakamura
    Yoshiyuki Kobayashi
    Kazuhiro Nouso
    Takahito Yagi
    Kazuhide Yamamoto
    BMC Cancer, 11
  • [2] Loss of Runt-Related Transcription Factor 3 Expression Associated with Human Hepatocellular Carcinoma Progression and Prognosis
    Li, Jianguo
    Jiang, Xiaojie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (09) : 2285 - 2290
  • [3] Loss of Runt-Related Transcription Factor 3 Causes Development and Progression of Hepatocellular Carcinoma
    Shiraha, Hidenori
    Nishina, Shin-ichi
    Yamamoto, Kazuhide
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (03) : 745 - 749
  • [4] Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
    Kataoka, Junro
    Shiraha, Hidenori
    Horiguchi, Shigeru
    Sawahara, Hiroaki
    Uchida, Daisuke
    Nagahara, Teruya
    Iwamuro, Masaya
    Morimoto, Hiroki
    Takeuchi, Yasuto
    Kuwaki, Kenji
    Onishi, Hideki
    Nakamura, Shinichiro
    Takaki, Akinobu
    Nouso, Kazuhiro
    Yagi, Takahito
    Yamamoto, Kazuhide
    Okada, Hiroyuki
    ONCOLOGY REPORTS, 2016, 35 (05) : 2576 - 2582
  • [5] Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma
    Tanaka, Shigetomi
    Shiraha, Hidenori
    Nakanishi, Yutaka
    Nishina, Shin-Ichi
    Matsubara, Minoru
    Horiguchi, Shigeru
    Takaoka, Nobuyuki
    Iwamuro, Masaya
    Kataoka, Junro
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Toshimori, Junichi
    Ohnishi, Hideki
    Takaki, Akinobu
    Nakamura, Shinichiro
    Nouso, Kazuhiro
    Yagi, Takahito
    Yamamoto, Kazuhide
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (11) : 2537 - 2546
  • [6] Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer
    Horiguchi, Shigeru
    Shiraha, Hidenori
    Nagahara, Teruya
    Kataoka, Jyunnro
    Iwamuro, Masaya
    Matsubara, Minoru
    Nishina, Shinichi
    Kato, Hironari
    Takaki, Akinobu
    Nouso, Kazuhiro
    Tanaka, Takehiro
    Ichimura, Koichi
    Yagi, Takahito
    Yamamoto, Kazuhide
    MOLECULAR ONCOLOGY, 2013, 7 (04) : 840 - 849
  • [7] Constitutive and functional expression of runt-related transcription factor-2 by microglial cells
    Nakazato, Ryota
    Takarada, Takeshi
    Watanabe, Takumi
    Binh Thanh Nguyen
    Ikeno, Shinsuke
    Hinoi, Eiichi
    Yoneda, Yukio
    NEUROCHEMISTRY INTERNATIONAL, 2014, 74 : 24 - 35
  • [8] Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma (vol 35, pg 2576, 2016)
    Kataoka, Junro
    Shiraha, Hidenori
    Horiguchi, Shigeru
    Sawahara, Hiroaki
    Uchida, Daisuke
    Nagahara, Teruya
    Iwamuro, Masaya
    Morimoto, Hiroki
    Takeuchi, Yasuto
    Kuwaki, Kenji
    Onishi, Hideki
    Nakamura, Shinichiro
    Takaki, Akinobu
    Nouso, Kazuhiro
    Yagi, Takahito
    Yamamoto, Kazuhide
    Okada, Hiroyuki
    ONCOLOGY REPORTS, 2017, 37 (03) : 1921 - 1921
  • [9] Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia
    Sun, Cheng-Cao
    Li, Shu-Jun
    Chen, Zhen-Long
    Li, Guang
    Zhang, Qian
    Li, De-Jia
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 12 : 103 - 111
  • [10] Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
    Zhang, Wenwen
    Ma, Qian
    Long, Bing
    Sun, Zhangyi
    Liu, Lingling
    Lin, Dongjun
    Zhao, Minyi
    FRONTIERS IN ONCOLOGY, 2021, 11